← back to search

Amy L. Cummings

APLA Health ·
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, and Genetic factors in colorectal cancer.
h-index
14
citations
1,426
works
203
NIH funding
primary concept
email

Recent publications

Transcriptomic biomarkers of therapeutic response to antibody-drug conjugates in metastatic breast cancer: A comprehensive multi-center study.
Journal of Clinical Oncology 2025cited by 3position: middledoi
A treatment-impact model of alectinib for the prediction of recurrence and associated costs in treating resectable ALK+ non-small cell lung cancer
Lung Cancer 2025cited by 0position: firstdoi
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Nature 2024cited by 145position: middledoi
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
Cancer Discovery 2023cited by 178position: middledoi
Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives
Journal of Thoracic Oncology 2023cited by 71position: middledoi
Consent document translation expense hinders inclusive clinical trial enrolment
Nature 2023cited by 28position: middledoi
Use of clinical RNA-sequencing in the detection of actionable fusions compared to DNA-sequencing alone.
Journal of Clinical Oncology 2022cited by 11position: middledoi
Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non–Small Cell Lung Cancer
Clinical Cancer Research 2019cited by 71position: middledoi
A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC
Journal of Thoracic Oncology 2018cited by 587position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Edward B. Garon · Cancer Clinic2 papers (2019–2023)Aaron Lisberg · Comprehensive Cardiovascular2 papers (2019–2023)Tristan Grogan · Norwegian Womens Public Health Association2 papers (2019–2023)Celina Ngiam · Gene Therapy Laboratory2 papers (2023–2025)David Elashoff · Los Angeles Medical Center2 papers (2019–2023)Jay M. Lee · McGill University Health Centre2 papers (2023–2025)Martin C. Stumpe · Tempus Labs (United States)1 papers (2022–2022)John Madrigal · The US Oncology Network1 papers (2019–2019)Marla Lipsyc-Sharf · APLA Health1 papers (2025–2025)Marcelo V. Negrão · The University of Texas MD Anderson Cancer Center1 papers (2023–2023) · 1 papers (2022–2022)Jesse Sussell · University of Alabama at Birmingham1 papers (2025–2025)Matthew D. Hellmann · Weill Cornell Medicine1 papers (2019–2019)Andrea Nañez · University of California, Los Angeles1 papers (2023–2023)Rachel Schiff · Baylor College of Medicine1 papers (2025–2025)Binyam Yilma · Tempus Labs (United States)1 papers (2025–2025)Eric M. Toloza · Moffitt Cancer Center1 papers (2023–2023)Katja Schulze · La Roche College1 papers (2023–2023)Jonathan W. Goldman · Industrial and Commercial Bank of China1 papers (2019–2019)Mark G. Kris · Kettering University1 papers (2023–2023)